Perspective Therapeutics, Inc. (CATX) › Net IncomePerspective Therapeutics, Inc. (CATX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2011: -$2.84M2012: -$3.49M2013: -$3.86M2014: -$5.96M2015: -$3.68M2016: -$4.71M2017: -$6.16M2018: -$6.70M2019: -$5.14M2020: -$3.45M2021: -$3.39M2022: -$10.76M2023: -$46.51M2024: -$79.28M2025: -$103.12M-$103.12M2011Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$103.12M-30.1%2024-$79.28M-70.5%2023-$46.51M-332.2%2022-$10.76M-217.7%2021-$3.39M+1.7%2020-$3.45M+33.0%2019-$5.14M+23.2%2018-$6.70M-8.7%2017-$6.16M-30.8%2016-$4.71M-28.0%2015-$3.68M+38.2%2014-$5.96M-54.5%2013-$3.86M-10.5%2012-$3.49M-22.8%2011-$2.84M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share